Dr. Iruka N Okeke
Professor, Pharmaceutical Microbiology
About Iruka
Throughout her career, Iruka Okeke has been drawn to studying the hard problems that most others have abandoned - like enteroaggregative Escherichia coli (E. coli), one of the most understudied causes of child illness in the world.
These bacteria are prevalent across Africa, and infected children can experience repeated or protracted bouts of diarrhea, washing out many of the nutrients they need to grow and develop. However, little is known about these pathogens, including which ones are harmful (many enteroaggregative E. coli resemble harmless E. coli) and what it is about them that cause disease.
Iruka is using whole genome sequencing data to identify the specific characteristics that the harmful E. coli have that make children sick and reveal which lineages should be prioritized for vaccine development.
Several years ago, Iruka was among the first scientists to push for bacterial whole genome sequencing to be conducted routinely in Africa. And for most of that time, she was often the only female microbiologist in the room. Now, she is training dozens of people, including many women, with the bioinformatic and genomic science skills needed to analyze the sequencing data.
"We need an army of people that can use the sequences and do something about endemic disease," said Iruka, whose desire to help build the next generation of African scientists also motivated her return to Nigeria in 2014 after 15 years abroad.
Later, when she looks back on her career accomplishments, she hopes her work as a mentor will have been just as impactful as the results she got in the lab.
"When I first got back people would say, 'are you planning to change science in Nigeria?' That would be nice, but what I really want to do is mentor young scientists," she said. "I'm one person but if I can train 10 people, and they train another 10 people, then you really get an exponential expansion in terms of what science can and will do."
Key Publications
The scope of the antimicrobial resistance challenge
Suboptimal Bacteriological Quality of Household Water in Municipal Ibadan, Nigeria
Grand Challenges Awards
Leveraging Bacterial Genomics for Health Solutions in Africa
Initiative: Grand Challenges Global Call-to-Action
Challenge: Calestous Juma Science Leadership Fellowship
Learn More About This Award
October 16, 2021
SARS-CoV-2 Sequencing for Oyo State and Nigeria
Initiative: Grand Challenges Global Call-to-Action
Challenge: Covid-19 Pathogen Genomic Sequencing (PGS) in Africa
Learn More About This Award
September 3, 2021
Anti-Adhesins with Therapeutic Potential for Enteroaggregative Escherichia Coli Diarrhoea
Initiative: Grand Challenges Global Call-to-Action
Challenge: Covid-19 Pathogen Genomic Sequencing (PGS) in Africa
Learn More About This Award
May 20, 2019
Minimal Genomics Lab for AMR Surveillance and Diagnostics in Provincial Low-income Settings
Initiative: Grand Challenges
Challenge: 2018 Grand Challenges Annual Meeting Call-to-Action
Learn More About This Award
March 8, 2019
Major Funding Awards and Honors
American Society for Microbiology Moselio Schaechter Award
Microbiology Society Peter Wildy Prize
In the News
The Case for Investing in Innovation and Collaboration
From Frontlines to Labs to Boardrooms: Women at the Center of Global Health & Development Innovation
Microbiology Society Peter Wildy Prize
Associated Gates Foundation Strategy
Vaccine Development and Surveillance
Our goal: